Lateral Femoral Cutaneous Nerve Block

2

Review clinical trials related to Lateral Femoral Cutaneous Nerve Block. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PENG+LFCN Block vs QIPB for Total Hip Arthroplasty

This randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve(LFCN) block in patients undergoing total hip arthroplasty. The primary outcome is the Numeric Rating Scale (NRS) within the first 48 hours after surgery. Secondary outcomes include postoperative total opioid consumption, ıncidence of quadriceps motor block, time to first ambulation, block performance time, falls, length of hospital stay, block- related complications(hematoma,local anesthetic systemic complications, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and incidence of postoperative nausea and vomiting.

Participants needed: 60
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Antalya City HospitalUpdated: Jun 25, 2026
Eligibility criteria

Age between 18 and 80 years [+5]

Refusal to participate [+14]

Status: Recruiting

Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries

This study aims to compare the analgesic efficacy and functional outcomes of blocking the nerve to the vastus lateralis (NVL) muscle versus the lateral femoral cutaneous nerve (LFCN).

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: Feb 6, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years. [+3]

Pregnancy. [+8]